HomeAI · summaries
Storia in 5 fonti
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Eli Lilly teams up with Caitlin Clark to bounce sports courts into Indianapolis neighborhoods
Eli Lilly has partnered with basketball star | Eli Lilly has partnered with basketball star Caitlin Clark’s foundation to open three multisport community courts across…
- ·
fiercehealthcare.com
How medication intelligence scales trust in healthcare tech innovation
Building a connected, AI-driven healthcare ecosystem requires more than tech integration; it demands trusted clinical content, medication intelligence, and explainable workflows.…
- ·
biopharmadive.com
Bristol Myers deepens AI investment with Anthropic deal
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many…
- ·
Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026
Doximity plans to accelerate its spending on artificial intelligence this year as it aims to become a leading AI platform for doctors. | The company plans to scale its clinical AI…
- ·
qz.com
Bristol-Myers Squibb deploys Anthropic Claude to 30,000 employees
The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs
- ·
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
- ·
WTW: Employers aiming to bulk up AI use for health and benefits
Employers are set to significantly increase their use of AI in health benefits, a new survey shows, even as they continue to face barriers to rolling out the tech. | Employers are…
- ·
cryptobriefing.com
Bristol Myers deploys Anthropic's Claude AI to accelerate drug discovery
Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees, embedding agentic AI into drug discovery, clinical trials, and manufacturing.
- ·
Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics are putting more pressure on the industry. |…
- ·
Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with details or first reports of three positive phase 3 trials. | Merck & Co. and Kelun-Biotech's sac-TMT is on fire…